These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 5765697)

  • 21. Biological properties and response to x-rays of first-generation transplants of spontaneous mammary carcinomas in C3H mice.
    Fowler JF; Sheldon PW; Begg AC; Hill SA; Smith AM
    Int J Radiat Biol Relat Stud Phys Chem Med; 1975 May; 27(5):463-80. PubMed ID: 1080142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An attempt at selective chemotherapy of hypoxic cells: triethylenemelamine and irradiation of a C3H mouse mammary tumour.
    Tannock IF; Marshall N; van Putten LM
    Eur J Cancer (1965); 1972 Oct; 8(5):501-7. PubMed ID: 4651785
    [No Abstract]   [Full Text] [Related]  

  • 23. Split-dose recovery in euoxic and hypoxic normal and tumor cells.
    Phillips TL
    Radiology; 1972 Oct; 105(1):127-34. PubMed ID: 5057293
    [No Abstract]   [Full Text] [Related]  

  • 24. Microfractionation. A particular type of pulsed irradiation in the treatment of mammary tumours in C3H mice.
    Stone J; Cheshire PJ
    Acta Radiol Ther Phys Biol; 1973 Feb; 12(1):71-80. PubMed ID: 4737664
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of fractionated doses of neutrons on C3H mouse mammary tumours.
    Fowler JF; Field SB; Denekamp J
    Eur J Cancer (1965); 1974 May; 10(5):281-5. PubMed ID: 4442430
    [No Abstract]   [Full Text] [Related]  

  • 26. Experimental evaluation of tumor bed effect for C3H mouse mammary carcinoma and for C3H mouse fibrosarcoma.
    Urano M; Suit HD
    Radiat Res; 1971 Jan; 45(1):41-9. PubMed ID: 5099671
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of hydroxyurea on the radiation response of C3H mouse mammary tumors.
    Piver MS; Howes AE; Suit HD; Marshall N
    Cancer; 1972 Feb; 29(2):407-12. PubMed ID: 5013540
    [No Abstract]   [Full Text] [Related]  

  • 28. Sensitizing ability and toxicity of iodoacetamide in radiotherapy of a C3H mouse mammary carcinoma.
    Urano M; Tanaka N; Hayashi S
    Br J Cancer; 1973 Aug; 28(2):190-3. PubMed ID: 4730179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential chemoprotection of normal and malignant tissues.
    Yuhas JM; Storer JB
    J Natl Cancer Inst; 1969 Feb; 42(2):331-5. PubMed ID: 5765464
    [No Abstract]   [Full Text] [Related]  

  • 30. Dose fractionation schedules--biologic aspects and applications to high LET radiotherapy.
    Fowler JF
    J Can Assoc Radiol; 1975 Mar; 26(1):40-3. PubMed ID: 806599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation and hyperthermal response of normal tissue in situ.
    Robinson JE; Wizenberg MJ; McCready WA
    Radiology; 1974 Oct; 113(1):195-8. PubMed ID: 4417998
    [No Abstract]   [Full Text] [Related]  

  • 32. Time-dose relationships in radiotherapy.
    Fowler JF; Thomlinson RH; Howes AE
    Eur J Cancer (1965); 1970 Jun; 6(3):207-21. PubMed ID: 4920612
    [No Abstract]   [Full Text] [Related]  

  • 33. Tumor control by irradiation: A C3H-He mouse mammary carcinoma in mammary-tumor-agent-positive and mammary-tumor-agent-free mice.
    Suit H; Kastelan A
    J Natl Cancer Inst; 1968 May; 40(5):945-50. PubMed ID: 5648138
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors.
    Raleigh JA; Chou SC; Arteel GE; Horsman MR
    Radiat Res; 1999 May; 151(5):580-9. PubMed ID: 10319731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
    Murata R; Tsujitani M; Horsman MR
    Radiother Oncol; 2008 Jun; 87(3):331-8. PubMed ID: 18375007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective enhancement of radiation response in a C3H mammary carcinoma by cisplatin.
    Overgaard J; Khan AR
    Cancer Treat Rep; 1981; 65(5-6):501-3. PubMed ID: 7195305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response of mouse skin and the C3HBA mammary carcinoma of the C3H mouse to x-rays and cyclotron neutrons: effect of mixed neutron-photon fractionation schemes.
    Nelson JS; Carpenter RE; Parker RG
    Eur J Cancer (1965); 1975 Dec; 11(12):891-901. PubMed ID: 1220974
    [No Abstract]   [Full Text] [Related]  

  • 38. Oxygen tension in mouse mammary carcinomas and osteosarcomas after irradiation with reactor fission neutrons.
    Weissfloch L; Auberger T; Senekowitsch-Schmidtke R; Wagner FM; Tempel K; Molls M
    Bull Cancer Radiother; 1996; 83 Suppl():32s-6s. PubMed ID: 8949748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
    Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
    Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normal tissue damage and tumor cure probability for irradiation given under different conditions of tissue oxygenation in hybrid mice.
    Suit H; Howard TC
    Radiology; 1967 Oct; 89(4):720-6. PubMed ID: 6059612
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.